Latest News
Agenus Inc.
- Agenus to Provide Third Quarter 2026 Financial Report and Development Update
- Agenus to announce third quarter 2026 financial results on November 5
- Agenus to Provide Third Quarter 2026 Financial Report and Development Update
- A Defining Moment for Cancer Immunotherapy During ESMO 2026 – Agenus
- Form 4 Agenus Inc: Thomas L. Harrison (Director) For: 1 October
- Armenia becomes first country to approve Agenus’ BOT+BAL cancer treatment combo
- Armenia Grants First Marketing Authorizations for Agenus’ BOT+BAL in Previously Treated MSS Metastatic Colorectal Cancer
- Armenia Grants First Marketing Authorizations For Agenus’ Bot+Bal In Previously Treated Mss Metastatic Colorectal Cancer
- Armenia Becomes First Country to Approve Agenus’ BOT+BAL for MSS Metastatic Colorectal Cancer
- Agenus: Pivot To Neoadjuvant Setting In CRC Sends Stock Soaring - But Caution Advised
- Agenus: Hot Times As It Trudges Towards BOT/BAL Submission (NASDAQ:AGEN)
- Rodman & Renshaw initiates Agenus stock with buy on cancer therapy
Headlines from the last 30 days, linking to the original publishers. See all market news →